Fundacion Instituto De Biologia Y Medicina Experimental
ADN, Cdad. Autónoma de Buenos Aires
- UEI
- KT13Y8KHDUS7
- CAGE
- WA301
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- Vuelta de Obligado 2490, C1428ADN ADN, Cdad. Autónoma de Buenos Aires, Argentina
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Role of actin cytoskeleton during mouse sperm acrosomal exocytosis | National Institutes of Health | $262,008 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Colorado State University | R01HD106968 | $194,400 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Trailhead Biosystems Inc. | Beachwood, OH | 325414 Biological Product (except Diagnostic) Manufacturing |
| Fundacio Institut De Recerca Biomedica (Irb Barcelona) | Barcelona, CT | — |
| Chubu University | Kasugai, Aichi | — |
| I.r.c.m. | Montréal, QC | — |
| Sino Biological US Inc. | Paoli, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Fundacion Instituto De Biologia Y Medicina Experimental is a non-profit organization registered to receive federal awards from the U.S. government. It has been registered in SAM.gov since September 2008 and its registration is currently set to expire in October 2024.
Fundacion Instituto De Biologia Y Medicina Experimental has primarily served as a sub-awardee on federal grants related to biomedical research. Through a sub-award from Colorado State University, Fundacion Instituto De Biologia Y Medicina Experimental has been responsible for conducting biochemical experiments, enzymatic assays, Western immunoblottings, flow cytometry experiments, and generating a conditional CDC42 knockout mouse model to evaluate fertility, hyperactivation, calcium levels, and spindle assembly checkpoint activity. Fundacion Instituto De Biologia Y Medicina Experimental has also collaborated with the University of Miami on grants funded by the National Institutes of Health to study viral oncogenesis, specifically related to Kaposi's sarcoma-associated herpesvirus (KSHV) and human papillomavirus (HPV). This work has involved investigating the role of galectins in regulating signaling pathways, angiogenesis, and oncogenic inflammation in virally-induced cancers like Kaposi's sarcoma and cervical cancer. The research aims to identify phenotypic characteristics of these cancers, elucidate pathogenic mechanisms, and explore novel therapeutic approaches targeting galectin-glycan interactions.
Quick answers
Is Fundacion Instituto De Biologia Y Medicina Experimental registered in SAM.gov?
Yes. Fundacion Instituto De Biologia Y Medicina Experimental's SAM.gov registration is active through September 4, 2027.
What is Fundacion Instituto De Biologia Y Medicina Experimental's most recent federal award?
Fundacion Instituto De Biologia Y Medicina Experimental's most recent federal grant award is Role of actin cytoskeleton during mouse sperm acrosomal exocytosis (R01TW008662), from National Institutes of Health, on March 9, 2012.
On GovTribe
See Fundacion Instituto De Biologia Y Medicina Experimental's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors